AWM
Altium Wealth Management Portfolio holdings
AUM
$1.39B
1-Year Return
12.44%
This Quarter Return
+7.18%
1 Year Return
-12.44%
3 Year Return
+24.96%
5 Year Return
–
10 Year Return
–
AUM
$1.55B
AUM Growth
+$152M
(+11%)
Cap. Flow
+$61.7M
Cap. Flow
% of AUM
3.97%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
404
New
27
Increased
223
Reduced
106
Closed
14
Top Buys
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$10.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$8.7M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$3.89M |
| 4 |
Invesco Variable Rate Preferred ETF
VRP
|
$3.37M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$2.88M |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$4.14M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$1.1M |
| 3 |
Vanguard S&P 500 Growth ETF
VOOG
|
$553K |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
$451K |
| 5 |
Banco Santander
SAN
|
$449K |
Sector Composition
| 1 | Technology | 9.29% |
| 2 | Financials | 6.68% |
| 3 | Healthcare | 3.78% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Communication Services | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Criteo
CRTO
$1.22B
| $1.03M | 0.07% |
26,418
-658
| -2% | -$25.6K |
|
152
Vanguard Dividend Appreciation ETF
VIG
$95.8B
| $1M | 0.06% |
5,821
-302
| -5% | -$51.9K |
|
153
Financial Select Sector SPDR Fund
XLF
$53.2B
| $1M | 0.06% |
25,602
+139
| +0.5% | +$5.43K |
|
154
SAP
SAP
$313B
| $987K | 0.06% |
7,045
-296
| -4% | -$41.5K |
|
155
GE Aerospace
GE
$296B
| $973K | 0.06% |
16,534
+1,655
| +11% | +$97.4K |
|
156
Clorox
CLX
$15.5B
| $966K | 0.06% |
5,539
+2,836
| +105% | +$495K |
|
157
Capital One
COF
$142B
| $963K | 0.06% |
6,640
+101
| +2% | +$14.6K |
|
158
Ameriprise Financial
AMP
$46.1B
| $959K | 0.06% |
3,180
+58
| +2% | +$17.5K |
|
159
General Motors
GM
$55.5B
| $931K | 0.06% |
15,879
+1,348
| +9% | +$79K |
|
160
Health Care Select Sector SPDR Fund
XLV
$34B
| $918K | 0.06% |
6,519
+24
| +0.4% | +$3.38K |
|
161
Analog Devices
ADI
$122B
| $914K | 0.06% |
5,201
+948
| +22% | +$167K |
|
162
Tourmaline Bio
TRML
$687M
| $910K | 0.06% |
+5,952
| New | +$910K |
|
163
Bristol-Myers Squibb
BMY
$96B
| $907K | 0.06% |
14,539
-2,234
| -13% | -$139K |
|
164
Consolidated Edison
ED
$35.4B
| $903K | 0.06% |
10,582
+2,932
| +38% | +$250K |
|
165
Truist Financial
TFC
$60B
| $895K | 0.06% |
15,278
+2,189
| +17% | +$128K |
|
166
S&P Global
SPGI
$164B
| $894K | 0.06% |
1,895
+179
| +10% | +$84.4K |
|
167
Aon
AON
$79.9B
| $891K | 0.06% |
2,965
+613
| +26% | +$184K |
|
168
Vanguard High Dividend Yield ETF
VYM
$64.2B
| $889K | 0.06% |
7,926
-927
| -10% | -$104K |
|
169
ServiceNow
NOW
$190B
| $885K | 0.06% |
1,364
+192
| +16% | +$125K |
|
170
Southern Company
SO
$101B
| $883K | 0.06% |
12,871
+720
| +6% | +$49.4K |
|
171
Barclays
BCS
$69.1B
| $877K | 0.06% |
84,759
-676
| -0.8% | -$7K |
|
172
Exelon
EXC
$43.9B
| $862K | 0.06% |
20,921
+1,660
| +9% | +$68.4K |
|
173
Norfolk Southern
NSC
$62.3B
| $860K | 0.06% |
2,888
-1,164
| -29% | -$347K |
|
174
Novartis
NVS
$251B
| $853K | 0.06% |
9,755
-3,127
| -24% | -$273K |
|
175
Stryker
SYK
$150B
| $836K | 0.05% |
3,128
-291
| -9% | -$77.8K |
|